What is Replimune Group's cumulative cost basis?

Replimune Group (REPL) reported cumulative cost basis of $29.81M in Q4 2025.

How has Replimune Group's cumulative cost basis changed year-over-year?

Replimune Group's cumulative cost basis increased by 13.9% year-over-year, from $26.17M to $29.81M.

What is the long-term trend for Replimune Group's cumulative cost basis?

Over 4 years (2021 to 2025), Replimune Group's cumulative cost basis has grown at a 28.1% compound annual growth rate (CAGR), from $10.09M to $27.14M.

Replimune Group REPL Cumulative Cost Basis

Cumulative Cost Basis at other companies

AmgenAMGN

——

Regeneron PharmaceuticalsREGN

——

Inhibrx Biosciences, Inc.INBX

——

Arcus BiosciencesRCUS

——

Tango TherapeuticsTNGX

——

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Operating income-$71.9M-8.9%

Net income-$70.9M-6.9%

EPS (diluted)-$0.77+2.5%

Balance sheet

See full

Cash & equivalents$124.7M-28.3%

Total debt$79.2M+0.5%

Total equity$210.5M-56.4%

Total assets$333.6M-44.7%

Cash flow

See full

Operating cash flow-$66.0M-30.1%

CapEx$135.0K-92.5%

Free cash flow-$66.1M-25.9%

Valuation

See full

Market cap$930.59M+28.6%

Enterprise value$885.15M+28.3%

Returns & leverage

See full

Return on equity-90.9%+362pp

Debt / equity0.4×+0.2×

Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Replimune Group's cumulative cost basis?: Replimune Group (REPL) reported cumulative cost basis of $29.81M in Q4 2025.
How has Replimune Group's cumulative cost basis changed year-over-year?: Replimune Group's cumulative cost basis increased by 13.9% year-over-year, from $26.17M to $29.81M.
What is the long-term trend for Replimune Group's cumulative cost basis?: Over 4 years (2021 to 2025), Replimune Group's cumulative cost basis has grown at a 28.1% compound annual growth rate (CAGR), from $10.09M to $27.14M.